Journal News Archive

| Advanced Search | Total contents: 72 | Total contents visits: 106,769 |
Show contents published from   To


:: CDC: COVID-19 vaccines recommended for young children - 2022/06/27 -
:: FDA Approves Risankizumab-rzaa for Moderately to Severely Active Crohn Disease - 2022/06/21 -
:: FDA Withdraws Umbralisib Due to Elevated Mortality Risk - 2022/06/6 -
:: Could some arthritis drugs reduce Alzheimer and related dementias risk in those with heart disease? - 2022/05/16 -
:: Cardiac Issues After COVID Infection and Vaccination: New Data - 2022/04/24 -
:: FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers - 2022/04/24 -
:: Pembrolizumab vs. placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma - 2022/04/5 -
:: Audio Interview: Effectiveness of Covid-19 Vaccination in Children - 2022/04/5 -
:: Compatibility of Commonly Used IV Drugs - 2022/02/20 -
:: FDA Delays Advisory Meeting for COVID-19 Vaccine for Very Young Kids - 2022/02/13 -
:: Omicron’s Differences, Sense of Smell, Effects on the Brain and Other News - 2022/02/13 -
:: FDA Limits Use of Monoclonal Antibodies to Treat COVID-19 - 2022/01/26 -
:: EHR Tool Flags Iron Deficiency In Heart Failure - 2022/01/16 -
:: Omicron wave: 9 in 10 pharmacies struggling with staff absences - 2022/01/16 -
:: No more annual flu shot? New target for universal influenza vaccine - 2022/01/8 -
:: Could vitamin D deficiency increase the risk of heart disease? - 2022/01/8 -
:: Immune Cell Population Potentially Responsible for Inflammation in Multiple Sclerosis - 2022/01/1 -
:: Coronavirus Can Spread to Heart, Brain Days After Infection - 2021/12/29 -
:: FDA Gives Nod to Tralokinumab for Adults With Moderate to Severe AD - 2021/12/29 -
:: Japan Health Panel Approves Merck's Oral COVID-19 Treatment - 2021/12/28 -
:: Positive Phase 3 Topline Results for Early Parkinson's Drug - 2021/12/28 -
:: Abrocitinib Approved for Atopic Dermatitis in Europe - 2021/12/14 -
:: Major COVID-19 Case Growth Expected in Coming Weeks - 2021/12/14 -
:: Feds Go on Offense Ahead of Potential Omicron Spread in US - 2021/12/5 -
:: New COVID Variant of Concern Drives US Travel Bans - 2021/11/27 -
Page 1 from 3    
First
Previous
1
 

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb